Fusions of NRG1 and a few different partner genes have been described in other tumors as well, namely in ovarian cancer: SETD4 [9], TSHZ2 [9], ZMYM2 [9], RAB3IL1 [25], and CLU [25,34], and in pancreatic ductal adenocarcinoma: VTCN1 [9], CDH1 [9], CDH6 [35], SARAF [10,35], APP [36], and CDK1 [37]. The gene discussed is NRG1; the disease is ovarian carcinoma.